- The Cardiology Advisor

Industry Supported Education

Exploring Earlier Initiation of Treatment for Pulmonary Arterial Hypertension (PAH)

Sponsored by the Janssen Pharmaceutical Companies of Johnson & Johnson Pulmonary arterial hypertension (PAH) is a progressive disease associated with elevated blood pressure in the pulmonary arteries, which carry blood from the right side of the heart to the lungs.1 Patients with PAH can experience frequent hospitalizations as their disease progresses,2 and as many as…

Next post in News